D C Allred

Summary

Affiliation: Texas Medical Center
Country: USA

Publications

  1. pmc Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer
    Sangjun Lee
    Breast Center, Baylor College of Medicine, Houston, Texas, USA
    Breast Cancer Res 8:R6. 2006
  2. ncbi request reprint Histological and biological evolution of human premalignant breast disease
    D C Allred
    The Breast Center, Baylor College of Medicine, Houston, Texas 77030, USA
    Endocr Relat Cancer 8:47-61. 2001
  3. pmc The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
    D Craig Allred
    Breast Center Department of Pathology, Baylor College of Medicine, Houston, Texas, USA
    Breast Cancer Res 6:240-5. 2004
  4. ncbi request reprint Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase
    M Carolina Gutierrez
    Breast Center and Department of Pathology, Baylor College of Medicine, Houston, TX, USA
    J Clin Oncol 23:2469-76. 2005
  5. ncbi request reprint Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study
    R M Elledge
    Baylor College of Medicine, Houston, TX, USA
    Int J Cancer 89:111-7. 2000
  6. ncbi request reprint Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers
    Yee Lu Tham
    Breast Center and the Department of Medicine, Baylor College of Medicine and The Methodist Hospital, Houston, TX 77030, USA
    Breast Cancer Res Treat 94:279-84. 2005
  7. ncbi request reprint Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates
    Torsten A Hopp
    Department of Medicine, and Breast Center, Baylor College of Medicine, Houston, Texas 77030, USA
    Clin Cancer Res 10:2751-60. 2004
  8. ncbi request reprint A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions
    S A Fuqua
    Breast Center, Baylor College of Medicine, Houston, Texas 77030, USA
    Cancer Res 60:4026-9. 2000
  9. ncbi request reprint Biological features of premalignant disease in the human breast
    D C Allred
    Breast Center, Baylor College of Medicine, Houston, Texas 77030, USA
    J Mammary Gland Biol Neoplasia 5:351-64. 2000
  10. ncbi request reprint HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study
    Grazia Arpino
    Breast Center, Baylor College of Medicine, Methodist Hospital, Houston, Texas, USA
    Clin Cancer Res 10:5670-6. 2004

Collaborators

Detail Information

Publications56

  1. pmc Hormones, receptors, and growth in hyperplastic enlarged lobular units: early potential precursors of breast cancer
    Sangjun Lee
    Breast Center, Baylor College of Medicine, Houston, Texas, USA
    Breast Cancer Res 8:R6. 2006
    ....
  2. ncbi request reprint Histological and biological evolution of human premalignant breast disease
    D C Allred
    The Breast Center, Baylor College of Medicine, Houston, Texas 77030, USA
    Endocr Relat Cancer 8:47-61. 2001
    ....
  3. pmc The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
    D Craig Allred
    Breast Center Department of Pathology, Baylor College of Medicine, Houston, Texas, USA
    Breast Cancer Res 6:240-5. 2004
    ....
  4. ncbi request reprint Molecular changes in tamoxifen-resistant breast cancer: relationship between estrogen receptor, HER-2, and p38 mitogen-activated protein kinase
    M Carolina Gutierrez
    Breast Center and Department of Pathology, Baylor College of Medicine, Houston, TX, USA
    J Clin Oncol 23:2469-76. 2005
    ..To evaluate growth factor receptor cross talk with the estrogen receptor (ER) in paired clinical breast cancer specimens and in a xenograft model before tamoxifen and at tumor progression as a possible mechanism for tamoxifen resistance...
  5. ncbi request reprint Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study
    R M Elledge
    Baylor College of Medicine, Houston, TX, USA
    Int J Cancer 89:111-7. 2000
    ..09). Increasing ER and PgR by IHC, as by LBA, are thus significantly associated with a progressively better response and longer survival in ER(+) metastatic breast cancer. pS2 is also predictive in this setting...
  6. ncbi request reprint Clinical response to neoadjuvant docetaxel predicts improved outcome in patients with large locally advanced breast cancers
    Yee Lu Tham
    Breast Center and the Department of Medicine, Baylor College of Medicine and The Methodist Hospital, Houston, TX 77030, USA
    Breast Cancer Res Treat 94:279-84. 2005
    ....
  7. ncbi request reprint Breast cancer patients with progesterone receptor PR-A-rich tumors have poorer disease-free survival rates
    Torsten A Hopp
    Department of Medicine, and Breast Center, Baylor College of Medicine, Houston, Texas 77030, USA
    Clin Cancer Res 10:2751-60. 2004
    ..In general, PR-B are strong transcriptional activators, whereas PR-A can act as dominant repressors of PR-B and ER. Thus their balance may affect tamoxifen response in breast cancers...
  8. ncbi request reprint A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions
    S A Fuqua
    Breast Center, Baylor College of Medicine, Houston, Texas 77030, USA
    Cancer Res 60:4026-9. 2000
    ..These data suggest that this mutation may promote or accelerate the development of cancer from premalignant breast lesions...
  9. ncbi request reprint Biological features of premalignant disease in the human breast
    D C Allred
    Breast Center, Baylor College of Medicine, Houston, Texas 77030, USA
    J Mammary Gland Biol Neoplasia 5:351-64. 2000
    ..A large number of biological features have been evaluated in this setting during the past decade. This review discusses a few features that appear to be particularly important and have been studied in a relatively comprehensive manner...
  10. ncbi request reprint HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study
    Grazia Arpino
    Breast Center, Baylor College of Medicine, Methodist Hospital, Houston, Texas, USA
    Clin Cancer Res 10:5670-6. 2004
    ..Evidence of resistance from clinical studies has been inconsistent. The present study examined whether HER-2 gene amplification or HER-1 expression predicted response to tamoxifen...
  11. ncbi request reprint Developmental and hormonal signals dramatically alter the localization and abundance of insulin receptor substrate proteins in the mammary gland
    A V Lee
    The Breast Center, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
    Endocrinology 144:2683-94. 2003
    ..These data indicate that IRS undergo complex developmental and hormonal regulation in the mammary gland, and that IRS-1 is more likely to regulate mammary function in lactating mice than in virgin or pregnant mice...
  12. ncbi request reprint Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma
    J Chang
    Department of Biochemistry, Medicine and Computing, The Royal Marden Hospital, Sutton, Surrey, United Kingdom
    Cancer 89:2145-52. 2000
    ..The objective of this clinical study was to examine in vivo changes in apoptotic index (AI), Bcl-2 expression, proliferation (Ki-67 and S-phase fraction [SPF]), and ploidy as potential indicators of chemoresponsiveness...
  13. ncbi request reprint Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor
    Jenny Chang
    Breast Center at Baylor College of Medicine, Houston, Texas, USA
    Cancer 97:545-53. 2003
    ..Therefore, the authors tested the hypothesis that the characteristics of primary breast tumors are important determinants of prognosis and survival in patients with metastatic breast carcinoma...
  14. ncbi request reprint Biomarker profile and genetic abnormalities in lobular carcinoma in situ
    Syed K Mohsin
    The Breast Center and Department of Pathology, Baylor College of Medicine, One Baylor Plaza MS 600, Houston, TX 77030, USA
    Breast Cancer Res Treat 90:249-56. 2005
    ..Our findings suggest that five known prognostic factors in IBC do not have prognostic utility in LCIS. Multiple genetic mechanisms may be involved in the development of LCIS...
  15. ncbi request reprint Lobular neoplasia on core-needle biopsy--clinical significance
    Grazia Arpino
    Breast Center, Baylor College of Medicine and The Methodist Hospital, Houston, Texas 77030, USA
    Cancer 101:242-50. 2004
    ..The goal of the current study was to determine the incidence of breast carcinoma at sites of core biopsy exhibiting LN compared with sites of core biopsy exhibiting ADH...
  16. ncbi request reprint Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients
    Jenny C Chang
    Breast Center, Department of Medicine, Baylor College of Medicine, 1 Baylor Plaza, MS 600, Houston, TX 77030, USA
    J Clin Oncol 23:1169-77. 2005
    ..Chemotherapy for operable breast cancer decreases the risk of death. Docetaxel is one of the most active agents in breast cancer, but resistance or incomplete response is frequent...
  17. ncbi request reprint Morphologic and immunophenotypic markers as surrogate endpoints of tamoxifen effect for prevention of breast cancer
    Syed K Mohsin
    Breast Center at Baylor College of Medicine, The Methodist Hospital, Houston, TX 77030, USA
    Breast Cancer Res Treat 94:205-11. 2005
    ..Proliferation, determined by Ki67 staining, was not significantly changed. Clinical trials of this type are difficult to carry out and modifications in trial design are needed to make this process more efficient...
  18. ncbi request reprint Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study
    Syed K Mohsin
    The Breast Center, Baylor College of Medicine, Houston, TX 77030, USA
    Mod Pathol 17:1545-54. 2004
    ..Progesterone receptor assessed by immunohistochemistry provides useful information about clinical outcome and it is better than progesterone receptor measured by ligand-binding assay...
  19. ncbi request reprint Biological and genetic properties of the p53 null preneoplastic mammary epithelium
    Daniel Medina
    Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA
    FASEB J 16:881-3. 2002
    ....
  20. ncbi request reprint Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer
    C Kent Osborne
    Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA
    J Natl Cancer Inst 95:353-61. 2003
    ....
  21. ncbi request reprint Molecular heterogeneity of inflammatory breast cancer: a hyperproliferative phenotype
    Dang M Nguyen
    Breast Center, Baylor College of Medicine and The Methodist Hospital, Houston, Texas 77030, USA
    Clin Cancer Res 12:5047-54. 2006
    ..The aims of this study are (a) to prospectively identify differential gene expression patterns associated with IBC and (b) to confirm these pathways using tissue arrays...
  22. ncbi request reprint Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
    Jenny C Chang
    Breast Center and the Departments of Medicine, Pathology, and Molecular and Cellular Biology, Baylor College of Medicine, and The Methodist Hospital, Houston, TX 77030, USA
    Lancet 362:362-9. 2003
    ..Patients often have de novo resistance or incomplete response to docetaxel, one of the most active agents in this disease. We postulated that gene expression profiles of the primary breast cancer can predict the response to docetaxel...
  23. ncbi request reprint Neoadjuvant trastuzumab induces apoptosis in primary breast cancers
    Syed K Mohsin
    Breast Center at Baylor College of Medicine The Methodist Hospital, 1 Baylor Plaza, MS 600, Houston, TX 77030, USA
    J Clin Oncol 23:2460-8. 2005
    ..Greater understanding of the cellular response in trastuzumab-treated patients will provide insight into the clinical management of patients...
  24. ncbi request reprint Breast tumors that overexpress nuclear metastasis-associated 1 (MTA1) protein have high recurrence risks but enhanced responses to systemic therapies
    Michelle D Martin
    Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA
    Breast Cancer Res Treat 95:7-12. 2006
    ..Tamoxifen and/or anthracylcene-based chemotherapies eliminated all MTA1 associations with clinical outcome, suggesting MTA1 overexpression predicts early disease relapse, but sensitizes breast tumors to systemic therapies...
  25. ncbi request reprint Neoadjuvant trastuzumab and docetaxel in breast cancer: preliminary results
    Andrea E Van Pelt
    Department of Surgery, Methodist Hospital, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    Clin Breast Cancer 4:348-53. 2003
    ..A high rate of brain metastasis was noted, particularly in patients with baseline metastatic disease...
  26. ncbi request reprint Constitutive activation of smoothened (SMO) in mammary glands of transgenic mice leads to increased proliferation, altered differentiation and ductal dysplasia
    Ricardo C Moraes
    Baylor Breast Center and Department of Molecular and Cellular Biology, Room N1210 MS BCM600, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    Development 134:1231-42. 2007
    ..Our data suggest that altered hedgehog signaling may contribute to breast cancer development by stimulating proliferation, and by increasing the pool of division-competent cells capable of anchorage-independent growth...
  27. ncbi request reprint Loss of heterozygosity events impeding breast cancer metastasis contain the MTA1 gene
    M D Martin
    Breast Center, Baylor College of Medicine, Houston, Texas 77030, USA
    Cancer Res 61:3578-80. 2001
    ..Toh et al., J. BIOL: CHEM:, 269: 22958-22963, 1994.), mapped to the center of our 1.6-Mb target region. Thus, MTA1 represents a strong candidate for this breast cancer metastasis-promoting gene...
  28. ncbi request reprint Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancer
    G Arpino
    Breast Care Center, Baylor College of Medicine, 6550 Fannin Street, Houston, TX 77030, USA
    Breast Cancer Res Treat 92:69-75. 2005
    ....
  29. pmc Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2
    Robert K Dearth
    Breast Cancer, Baylor College of Medicine and Methodist Hospital, Department of Medicine, Houston, TX 77030, USA
    Mol Cell Biol 26:9302-14. 2006
    ..This study defines IRSs as oncogene proteins in vivo and provides new models to develop inhibitors against IRSs for anticancer therapy...
  30. ncbi request reprint Estrogen receptor beta protein in human breast cancer: correlation with clinical tumor parameters
    Suzanne A W Fuqua
    Department of Medicine, Breast Center, Baylor College of Medicine, Houston, Texas 77030, USA
    Cancer Res 63:2434-9. 2003
    ..These results suggest that ERbeta expression is not a surrogate for ERalpha in clinical breast tumors and, as such, could be a useful biomarker in its own right...
  31. pmc Introduction of oncogenes into mammary glands in vivo with an avian retroviral vector initiates and promotes carcinogenesis in mouse models
    Zhijun Du
    Breast Center, Baylor College of Medicine, Houston, TX 77030, USA
    Proc Natl Acad Sci U S A 103:17396-401. 2006
    ..We conclude that infection of mammary glands with retrovirus vectors is an efficient means to screen candidate oncogenes for their capacity to initiate or promote mammary carcinogenesis in the mouse...
  32. ncbi request reprint Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma
    Jianzhou Wang
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 94:3107-14. 2002
    ..In this study, the authors investigated the roles of tumor nuclear grade, mitotic activity, and biomarker expression profiles in predicting the pathologic response of breast tumors to preoperative chemotherapy...
  33. ncbi request reprint Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma
    R W Brown
    Department of Pathology, Baylor College of Medicine, Houston, TX
    Hum Pathol 24:347-54. 1993
    ..3, and Leu-M1 resulted in eight possible phenotypes that resolved 74% of cases (101 of 137 cases), with even further reduced risk of false-negative results.(ABSTRACT TRUNCATED AT 400 WORDS)..
  34. ncbi request reprint A roundtable discussion of aromatase inhibitors as therapy for breast cancer
    D Craig Allred
    Baylor College of Medicine, Houston, Texas, USA
    Breast J 9:213-22. 2003
    ..Finally, recent results suggest that anastrozole may be superior to tamoxifen as adjuvant therapy for early stage disease in postmenopausal women with hormone-responsive disease...
  35. ncbi request reprint Progesterone-action in the murine uterus and mammary gland requires steroid receptor coactivator 2: relevance to the human
    Rodrigo Fernandez-Valdivia
    Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA
    Front Biosci 12:3640-7. 2007
    ..Finally, the observation that SRC-2 is also expressed in many of the same cell-types in the human, underscores the importance of further study of this coregulator's role in both peri-implantation biology and mammary development...
  36. ncbi request reprint Steroid receptor coactivator 2 is essential for progesterone-dependent uterine function and mammary morphogenesis: insights from the mouse--implications for the human
    Atish Mukherjee
    Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    J Steroid Biochem Mol Biol 102:22-31. 2006
    ....
  37. ncbi request reprint Development of standard estrogen and progesterone receptor immunohistochemical assays for selection of patients for antihormonal therapy
    Therese Phillips
    Dako North America, Inc, Carpinteria, CA 93013, USA
    Appl Immunohistochem Mol Morphol 15:325-31. 2007
    ....
  38. doi request reprint Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution
    D Craig Allred
    Department of Pathology, Washington University School of Medicine, St Louis, MO 63110, USA
    Clin Cancer Res 14:370-8. 2008
    ..Human invasive breast cancers (IBC) show enormous histologic and biological diversity. This study comprehensively evaluated diversity in ductal carcinoma in situ (DCIS), the immediate precursors of IBCs...
  39. pmc Alterations of gene expression in the development of early hyperplastic precursors of breast cancer
    Sangjun Lee
    Department of Pathology and Immunology, Washington University School of Medicine, St Louis, MO 63110, USA
    Am J Pathol 171:252-62. 2007
    ..Because HELUs are such early potential precursors of breast cancer, targeting some of these alterations may be especially promising strategies for breast cancer prevention...
  40. ncbi request reprint Estrogen receptor positive breast cancer metastasis: altered hormonal sensitivity and tumor aggressiveness in lymphatic vessels and lymph nodes
    Joshua Chuck Harrell
    Department of Medicine, University of Colorado Health Sciences Center, Aurora, Colorado 80045, USA
    Cancer Res 66:9308-15. 2006
    ..We hypothesize that CD44 expression targets tumor cells for transport to, and uptake in, LNs. If so, the CD44 pathway could be targeted therapeutically to slow or prevent LN metastases...
  41. ncbi request reprint Oophorectomy and tamoxifen adjuvant therapy in premenopausal Vietnamese and Chinese women with operable breast cancer
    Richard R Love
    University of Wisconsin Comprehensive Cancer Center, 610 Walnut Street, Madison, WI 53705 2397, USA
    J Clin Oncol 20:2559-66. 2002
    ..Approximately 350,000 new cases of breast cancer are diagnosed annually in premenopausal Asian women who have lower levels of estrogen than western women...
  42. doi request reprint Problems and solutions in the evaluation of hormone receptors in breast cancer
    D Craig Allred
    J Clin Oncol 26:2433-5. 2008
  43. pmc The polarity protein Par6 induces cell proliferation and is overexpressed in breast cancer
    Marissa E Nolan
    Graduate Program in Genetics, Stony Brook University, Stony Brook, New York, USA
    Cancer Res 68:8201-9. 2008
    ..Thus, in addition to regulating cell polarization processes, Par6 is an inducer of cell proliferation in breast epithelial cells...
  44. ncbi request reprint Her-2/neu overexpression and response to oophorectomy plus tamoxifen adjuvant therapy in estrogen receptor-positive premenopausal women with operable breast cancer
    Richard R Love
    Departments of Medicine and Biostatistics and Medical Informatics, University of Wisconsin, Madison, WI 53726, USA
    J Clin Oncol 21:453-7. 2003
    ....
  45. ncbi request reprint The HOXB13:IL17BR expression index is a prognostic factor in early-stage breast cancer
    Xiao Jun Ma
    AviaraDx Inc, Carlsbad, CA, USA
    J Clin Oncol 24:4611-9. 2006
    ..Confirmation in larger independent patient cohorts was needed to fully validate their clinical utility...
  46. ncbi request reprint Estradiol regulates different genes in human breast tumor xenografts compared with the identical cells in culture
    Djuana M E Harvell
    Department of Medicine, University of Colorado Health Sciences Center at Fitzsimons, Aurora, 80045, USA
    Endocrinology 147:700-13. 2006
    ..This indicates the extent to which gene expression profiles are uniquely dependent on hormone-treatment times and the cellular microenvironment...
  47. ncbi request reprint Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer
    Richard R Love
    Department of Medicine, Section of Medical Oncology, University of Wisconsin School of Medicine, Madison, 53705, USA
    J Natl Cancer Inst 94:662-9. 2002
    ..We investigated this question in the context of a clinical trial comparing mastectomy alone with mastectomy plus adjuvant oophorectomy and tamoxifen in premenopausal women with operable breast cancer...
  48. ncbi request reprint Image-detected breast cancer: state of the art diagnosis and treatment
    Melvin J Silverstein
    USC Norris Cancer Center, Los Angeles 90033, USA
    J Am Coll Surg 201:586-97. 2005
  49. ncbi request reprint Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women
    Hazel B Nichols
    University of Wisconsin Comprehensive Cancer Center, Madison, WI, USA
    Cancer Epidemiol Biomarkers Prev 14:41-7. 2005
    ..Our findings support the hypothesis that some breast cancer risk factors differ by ER and HER-2/neu tumor marker subtypes...
  50. doi request reprint Response and resistance to the endocrine prevention of breast cancer
    Anthony Howell
    CRC Department Medical Oncology, University of Manchester Christie Hospital and Holt Radium Inst, Manchester, UK
    Adv Exp Med Biol 617:201-11. 2008
    ....
  51. ncbi request reprint Expression of renal cell carcinoma-associated markers erythropoietin, CD10, and renal cell carcinoma marker in diffuse malignant mesothelioma and metastatic renal cell carcinoma
    Kelly J Butnor
    Department of Pathology, University of Vermont Fletcher Allen Health Care, Burlington, VT 05401, USA
    Arch Pathol Lab Med 130:823-7. 2006
    ..Standard panels of immunohistochemical markers are of limited benefit...
  52. ncbi request reprint The estrogen paradox
    Richard J Santen
    Division of Endocrinology and Metabolism, University of Virginia Health Sciences Center, Charlottesville, VA 22908 1416, USA
    Nat Clin Pract Endocrinol Metab 3:496-7. 2007
  53. ncbi request reprint HER2 testing in breast cancer: NCCN Task Force report and recommendations
    Robert W Carlson
    Stanford Hospital and Clinics
    J Natl Compr Canc Netw 4:S1-22; quiz S23-4. 2006
    ..8 to 2.2 or average number of HER2 gene copies/cell in the range of greater than 4 to less than 6 are considered to be borderline, and strategies to assign the HER2 status of such samples are proposed...
  54. ncbi request reprint American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer
    Antonio C Wolff
    American Society of Clinical Oncology, Alexandria, VA, USA
    J Clin Oncol 25:118-45. 2007
    ..To develop a guideline to improve the accuracy of human epidermal growth factor receptor 2 (HER2) testing in invasive breast cancer and its utility as a predictive marker...
  55. ncbi request reprint Re: The influence of menstrual cycle phase on surgical treatment of primary breast cancer: have we made any progress over the past 13 years?
    Richard R Love
    J Natl Cancer Inst 94:1722-3; author reply 1723. 2002
  56. ncbi request reprint ER expression is not bimodal in breast cancer
    D Craig Allred
    Am J Clin Pathol 124:474-5; author reply 475-6. 2005